Levocetirizine Dihydrochloride Prices Trend | Pricing | News | Database | Chart

North America

In Q3 2024, the price of Levocetirizine Dihydrochloride in North America followed a consistent upward trajectory, shaped by a combination of demand and supply-side factors.

The growing demand for the product was fueled by heightened consumer confidence and a favorable economic climate, driving an uptick in orders and overall market activity. On the supply side, logistical challenges such as port congestion, delays, and adverse weather conditions constrained availability and placed upward pressure on prices. These disruptions prompted importers and retailers to stockpile inventory to mitigate potential shortages, further intensifying cost pressures. Blank sailings were among the key disruptions impacting the quarter. The United States experienced the sharpest price fluctuations, aligning with the broader North American trend.

Notably, prices increased by 2% compared to the previous quarter, with a 1% rise observed between the first and second halves of Q3. By the quarter’s end, the price for Levocetirizine Dihydrochloride (USP, FDA) CFR Los Angeles stood at USD 537,500 per metric ton, illustrating the combined effects of strong demand and persistent supply chain challenges.

Get Real time Prices for Levocetirizine Dihydrochloride: https://www.chemanalyst.com/Pricing-data/lovocetirizine-dihydrochloride-1436

Asia-Pacific

In Q3 2024, the pricing of Levocetirizine Dihydrochloride in the Asia-Pacific (APAC) region displayed a distinct upward trend, driven by robust demand and significant supply constraints.

The rise in demand stemmed from increased inquiries across domestic and international markets, alongside proactive stockpiling by businesses anticipating logistical uncertainties. This heightened activity put notable upward pressure on prices. On the supply side, rising input costs and production challenges exacerbated the limited availability of the product. Among APAC nations, China experienced the most significant price movements, reflecting the region’s dynamic market environment.

Despite a 2% decline compared to the previous quarter, Q3 witnessed a 1% price increase between the first and second halves, indicating strong market sentiment. By the end of the quarter, the price of Levocetirizine Dihydrochloride (USP, FDA) FOB Shanghai reached USD 513,000 per metric ton, showcasing the overall bullish trend influenced by demand surges and supply constraints.

Europe

In Q3 2024, Levocetirizine Dihydrochloride prices in Europe followed a noticeable upward trend, with Germany experiencing the most significant fluctuations.

Global maritime disruptions, including delays in key shipping routes, were a primary contributor to elevated costs, as they led to shortages and higher freight expenses. These logistical issues compounded supply chain pressures, limiting the product’s availability. Meanwhile, robust demand from end-user industries and preemptive stockpiling further drove prices higher. Germany, as the most dynamic market in the region, saw marked price variations due to these combined factors.

Seasonal influences were also apparent, with a 2% price difference between the first and second halves of Q3. Although prices dipped slightly compared to the previous quarter, the overall market sentiment remained optimistic. By the quarter’s close, Levocetirizine Dihydrochloride (USP, FDA) CFR Hamburg was priced at USD 530,400 per metric ton, reflecting the ongoing challenges of supply chain disruptions and robust demand in a bullish pricing environment.

Contact Us:

ChemAnalyst

GmbH – S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Call: +49-221-6505-8833

Email: [email protected]

Website: https://www.chemanalyst.com